Abstract
We report on a patient with severe ulcerative pyoderma gangrenosum that was recalcitrant to systemic corticosteroid, tumour necrosis factor antagonist and ciclosporin treatment and finally controlled when spesolimab was added to the treatment regimen.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have